Because of its central role in controlling the sensitivity of VSMCs to growth factors, LRP1 has been implicated through genome-wide association and animal studies in protection against a range of arterial diseases, including AAA [17], carotid [18] and coronary artery disease [19]. Here, LRP1 is linked to triple-A syndrome.